Peter B. Kang, MD | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
Healthcare Providers

Peter B. Kang, MD

Healthcare Provider
Chief, Division of Pediatric Neurology
UF Health Center of Pediatric Neuromuscular and Rare Diseases
University of Florida
2000 SW Archer Rd.
Second Floor
Gainesville, Florida, United States

Dr. Kang is a pediatric neurologist and physician-scientist whose clinical and research interests focus on neuromuscular disorders. Currently, he is Chief of the Division of Pediatric Neurology at the University of Florida Health. He is also associated as Professor of Pediatrics and Joint Professor of Neurology, Molecular Genetics & Microbiology at the University of Florida. Dr. Kang is a Fellow of the American Academy of Pediatrics and the American Academy of Neurology, serving on national committees for both organizations.

Dr. Kang’s research laboratory focuses on the genetics of muscular dystrophy and other pediatric neuromuscular disorders, along with the mechanisms of rare muscle diseases. The laboratory makes use of exome and genome sequencing technologies, supplemented as needed by linkage analyses and other approaches. Genes identified in the core project are considered for more in-depth studies to understand the disease processes better and to seek potential therapeutic targets. His work is supported by the National Institutes of Health and was previously supported by the Muscular Dystrophy Association.

 

Representative Publications:

Dollars and antisense for Duchenne muscular dystrophy: Eteplirsen and dystrophin

Clinical trial readiness in non-ambulatory boys and men with Duchenne muscular dystrophy: MDA-DMD network follow-up

Beyond the Gower’s sign: measuring outcomes in Duchenne muscular dystrophy

Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy

Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy

rareRelated